recent
year
new
group
virus
recogn
caus
respiratori
ill
man
prototyp
strain
design
ibvlik
viru
virus
shown
negativecontrast
electron
microscopi
resembl
morpholog
avian
infecti
bronchiti
viru
ibv
mous
hepat
viru
mhv
characterist
structur
resembl
share
properti
virus
caus
certain
virologist
propos
name
coronaviru
previous
unrecogn
group
although
hemagglutinin
detect
investig
use
avian
ibv
treat
differ
method
viru
agglutin
erythrocyt
normal
condit
far
hemagglutin
record
either
human
murin
strain
properti
hemagglutin
strain
ibvlik
viru
adapt
growth
suckl
mous
brain
form
basi
report
virus
ibvlik
viral
strain
oc
het
sm
oc
het
sm
control
mous
brain
harvest
sm
receiv
dr
kenneth
mcintosh
laboratori
viral
diseas
nation
institut
allergi
infecti
diseas
niaid
nation
institut
health
nih
bethesda
maryland
virus
isol
organ
cultur
human
embryon
trachea
patient
respiratori
ill
adapt
growth
suckl
mous
brain
viral
control
harvest
passag
laboratori
intracerebr
inocul
undilut
brain
suspens
swiss
white
mice
icr
coloni
mice
free
mhv
infect
mice
show
typic
encephalit
symptom
usual
within
hr
pool
strain
frozen
c
dead
mice
discard
frozen
mice
thaw
room
temperatur
brain
harvest
transoccipit
needl
punctur
syring
aspir
ten
percent
suspens
brain
made
tryptos
phosphat
broth
tpb
contain
gelatin
suspens
brain
store
c
control
mice
treat
manner
product
antigen
antigen
preparej
make
suspens
infect
normal
mous
brain
phosphat
buffer
salin
pb
ph
veron
buffer
diluent
vbd
ph
clarifi
refriger
centrifug
g
min
antigen
store
c
c
antisera
mous
antisera
strain
oc
control
mous
sera
pair
sera
patient
ibvlik
virus
isol
receiv
dr
mcintosh
dr
albert
kapikian
laboratori
viral
diseas
niaid
immun
sera
prepar
laboratori
intraperiton
intracerebr
inocul
weanl
mice
accord
method
mcintosh
et
al
mice
bled
day
inocul
pair
sera
children
particip
longitudin
survey
respiratori
diseas
also
select
studi
serolog
test
complement
fixat
cf
test
perform
use
laboratori
branch
complement
fixat
lbcf
test
adapt
microtit
techniqu
neutral
n
test
carri
suckl
mice
inocul
intracerebr
approxim
ld
viru
per
mi
equal
volum
antisera
dilut
pb
hemagglutinationinhibit
hi
test
perform
microtit
techniqu
pb
diluent
sera
inactiv
c
min
hemagglutin
ha
harvest
ninth
passag
ibvlik
strain
suckl
mous
brain
test
ha
varieti
speci
erythrocyt
c
room
temperatur
c
chicken
mous
rat
cell
agglutin
oc
oc
temperatur
tabl
rhesu
guinea
pig
cell
fail
agglutin
test
condit
human
vervet
cell
agglutin
c
rat
mous
erythrocyt
appear
sensit
agglutin
speci
particularli
room
temperatur
c
spontan
elut
erythrocyt
observ
period
hr
optim
ha
temperatur
howev
elut
occur
human
vervet
erythrocyt
agglutin
cell
transfer
c
room
temperatur
resuspens
reincub
cell
c
yield
origin
ha
titer
natur
hemagglutinin
standard
titrat
receptordestroy
enzym
rde
perform
investig
possibl
role
neuramin
acid
agglutin
erythrocyt
oc
oc
chicken
cell
treat
dilut
rde
fail
agglutin
presenc
standard
myxoviru
control
influenza
agglutin
treat
chicken
cell
ibvlik
virus
unaffect
even
lowest
dilut
rde
use
treatment
trypsin
ether
tween
plu
ether
complet
destroy
ha
activ
brain
antigen
tabl
heat
c
min
consider
reduc
activ
multipl
freez
thaw
cycl
notic
effect
sonic
oscil
increas
ha
titer
slightli
treatment
caus
decreas
ha
titer
also
produc
correspond
decreas
infect
ha
antigen
titer
virus
stabl
week
storag
c
c
wherea
complet
disappear
storag
c
period
time
ha
titer
antigen
held
room
temperatur
lost
week
relat
ha
cf
activ
infect
litter
mice
per
litter
inocul
intracerebr
mous
brain
suspens
oc
contain
approxim
suckl
mice
ld
viru
per
mi
two
litter
mice
sacrif
freez
c
interv
includ
typic
encephalit
syndrom
dead
mice
exclud
experi
brain
mice
harvest
period
time
divid
pool
suspens
made
tpb
determin
infect
pb
determin
ha
activ
vbd
titrat
cf
antigen
assay
infect
sampl
perform
intracerebr
inocul
mice
estim
ld
cf
titrat
perform
stepwis
dilut
antigen
constant
optim
dilut
antiserum
straightlin
determin
infect
increas
rapidli
ld
hr
ld
hr
figur
plateau
logio
ld
maintain
hr
ha
cf
antigen
titer
remain
hr
inocul
rapid
increas
titer
antigen
seen
hr
correspond
increas
infect
ld
cf
antigen
titer
remain
hr
ha
antigen
titer
increas
tabl
antigen
relationship
establishd
virus
studi
except
oneway
cross
hi
cf
ibvlik
viral
antigen
mous
hepat
polyval
antisera
tabl
previous
describ
nonspecif
inhibit
chicken
cell
hemagglutinin
encount
anim
human
sera
employ
suggest
special
method
serum
treatment
requir
puriti
strain
oc
oc
infect
titer
greater
ld
suckl
mice
fail
produc
cytopath
effect
chicken
cell
hemagglutinin
posit
guinea
pig
hemadsorpt
passag
primari
rhesu
monkey
kidney
wi
tissu
cultur
embryon
hen
egg
day
old
inocul
amniot
allanto
ha
detect
harvest
fluid
blood
agar
mycoplasma
media
sabouraud
sodium
thioglycol
broth
inocul
suspens
mous
brain
infect
ibvlik
viru
bacteri
mycoplasm
fungal
contamin
observ
sensit
variou
lot
mous
sera
immun
oc
oc
mhv
test
hi
neutral
andor
cf
homolog
heterolog
antigen
result
compar
tabl
oc
oc
indistinguish
test
titer
hi
antibodi
close
parallel
found
neutral
titer
cf
antibodi
lower
mhv
polyval
antiserum
react
ibvlik
antigen
cf
hi
titer
significantli
less
hi
cf
reciproc
cf
test
show
oneway
cross
mhv
ibvlik
virus
absenc
hemagglutinin
mhv
exist
oneway
cross
could
confirm
hi
superior
sensit
hi
test
cf
appar
human
sera
well
tabl
pair
sera
children
respiratori
patient
ibvlik
virus
isol
strain
ibvlik
virus
adapt
suckl
mous
brain
shown
agglutin
erythrocyt
speci
repres
first
time
member
coronaviru
group
demonstr
abil
without
certain
manipul
hemagglutin
ibvlik
virus
observ
earlier
studi
group
present
find
probabl
result
adapt
viru
growth
suckl
mous
brain
product
higher
titer
antigen
studi
growth
curv
oc
reveal
activ
ha
detect
infect
rose
ld
mechan
hemagglutin
ibvlik
virus
remain
determin
preliminari
evid
suggest
differ
myxovirus
sever
respect
unlik
certain
myxovirus
spontan
elut
hemagglutinin
optim
temperatur
incub
observ
although
elut
human
vervet
cell
occur
increas
temperatur
origin
ha
titer
could
restor
reincub
c
ha
appar
involv
receptor
site
erythrocyt
differ
requir
myxovirus
treatment
erythrocyt
neuraminidas
fail
inhibit
agglutin
ibvlik
virus
although
treatment
trypsin
ether
ether
often
enhanc
activ
ha
certain
myxovirus
treatment
destroy
hemagglutinin
ibvlik
virus
gener
treatment
caus
loss
infect
result
correspond
loss
ha
titer
hi
test
specif
crossreact
detect
hemagglutin
virus
test
timeconsum
procedur
treatment
serum
unnecessari
nonspecif
inhibitor
encount
heattreat
sera
varieti
sourc
use
lack
serolog
distinct
hi
strain
ibvlik
viru
oneway
cross
antigen
mhv
polyval
antisera
corrobor
earlier
find
cf
neutral
test
gener
titer
hi
antibodi
parallel
result
neutral
test
hi
test
also
sensit
titer
gener
higher
hi
cf
hi
test
detect
twice
mani
rise
antibodi
pair
sera
patient
respiratori
diseas
cf
sensit
hi
test
might
improv
use
erythrocyt
rat
mice
certain
disadvantag
inher
rat
mous
cell
difficult
obtain
often
yield
errat
ha
pattern
also
use
chicken
erythrocyt
elimin
procedur
remov
nonspecif
agglutinin
serum
adsorpt
advantag
hi
test
identif
virus
antigen
character
serodiagnosi
serosurvey
laboratori
procedur
well
recogn
test
prove
use
tool
studi
ibvlik
virus
well
abil
strain
ibvlik
virus
adapt
suckl
mous
brain
agglutin
certain
speci
erythrocyt
demonstr
mechan
hemagglutin
ibvlik
virus
unlik
myxovirus
sever
respect
notabl
neuramin
acid
receptor
involv
hemagglutinationinhibit
hi
test
chicken
erythrocyt
specif
hemagglutin
inhibit
antisera
wide
varieti
hemagglutin
virus
ident
strain
oc
oc
oneway
relationship
strain
mous
hepat
viru
previous
observ
neutral
complement
fixat
cf
test
confirm
hi
test
also
sensit
titer
gener
higher
twice
mani
posit
serolog
convers
patient
respiratori
diseas
detect
hi
cf
hi
test
prove
use
tool
studi
ibvlik
virus
